Nov 2023 – Oct 2025 · 1 yr 11 mos · Los Angeles, California, United States

• Launched and directed a biotech venture developing a game-inspired, AI-driven drug discovery platform, managing scientific direction, partnerships, and funding strategy.
• Designed and coordinated the overall scientific roadmap, aligning computational workflows, experimental validation, and business milestones.
• Secured $150k in competitive funding by articulating a clear scientific and commercial vision; selected as one of 17 global teams for the Nucleate Biotech Activator.
• Collaborated with mentors, investors, and scientific advisors to refine strategy, communicate progress, and adapt milestones to real-world feedback.
• Led a small interdisciplinary team, bridging computational modeling, game mechanics, and biotech strategy to accelerate drug candidate evaluation.
• Transformed complex scientific outcomes into investor decks, executive summaries, and program updates tailored for diverse stakeholders.
• Delivered a 54% reduction in computational expenses by optimizing project workflows and aligning team efforts with strategic objectives.

May 2023 – Dec 2023 · 7 mos · Remote

• Supported therapeutic innovation and product strategy in neuromodulation, translating data and research into actionable insights for cross-functional teams.
• Assessed medical claims data to identify prescription patterns and patient segments, providing clear recommendations that informed product positioning for vagus nerve stimulation (VNS) systems.
• Conducted in-depth review of treatment-resistant depression mechanisms and clinical trial landscapes; findings highlighted therapeutic gaps and shaped internal R&D priorities.
• Designed and executed primary research interviews with physicians, gathering qualitative insights that complemented quantitative analyses and sharpened strategy.
• Delivered concise, data-driven slide decks to leadership, translating complex evidence into strategic options for decision-making.

Sep 2021 – May 2022 · 8 mos · London, England, United Kingdom

• Contributed to large-scale antibody–antigen data initiatives, ensuring accuracy and usability of scientific datasets to support product development and customer needs.
• Supported development of a high-quality antibody database by standardizing and curating large-scale literature data.
• Translated complex immunology literature into structured, usable data products for internal teams and external stakeholders.
• Worked with product managers and technical staff to align data pipelines with company objectives, improving integration of scientific data into business operations.
• Recommended and implemented workflow improvements that increased annotation efficiency by 15%, enhancing team throughput.

Aug 2021 – Dec 2024 · 3 yrs 4 mos · London Area, United Kingdom

• Directed independent and collaborative research on protein structure, immune response, and genetic disease, with a focus on translating computational insights into clinical and scientific impact.
• Designed and managed a multi-year research program integrating computational biology, structural modeling, and clinical data to investigate coagulation and complement disorders.
• Authored and presented research at international symposia; published first-author work on a novel variant classification database, demonstrating ability to convey complex findings to both scientific and clinical audiences.
• Built and launched a global web database for Factor V deficiency, improving diagnostic accuracy and attracting >2,000 users worldwide.
• Partnered with clinicians and bioinformaticians on immune profiling studies, aligning computational single-cell analyses with biological and clinical questions.
• Created user-friendly applications and visualization tools that enabled non-computational collaborators to interpret genetic variants and protein structures.
• Translated research insights into actionable findings that informed rare disease variant classification and deepened understanding of immune mechanisms in surgical infections.

Dec 2020 – Jul 2021 · 7 mos · Nicosia, Cyprus

• Conducted experimental and computational research on liposomal nanoparticles to optimize miRNA delivery for cancer therapies, bridging lab work with translational goals.
• Supervised 30+ nanoparticle formulation experiments (DLS and electrophoresis) to systematically improve delivery efficiency by 25%.
• Collaborated with computational and experimental researchers to integrate lab findings with predictive modeling.
• Co-developed a predictive tool that linked nanoparticle composition with functional properties, supporting decision-making in formulation design.
• Summarized results for lab leadership and collaborators, aligning technical outputs with broader therapeutic objectives.